Levels of Matrix Metalloproteases in Bladder Cancer Correlate with Tumor Grade and Invasion

Cancer Research

Volumn 53, Issue 22, 1993, Pages 5365-5369

  Davies, Bernard ^a   Waxman, Jonathan ^b   Wasan, Harpret ^b   Abel, Paul ^b   Williams, Gordon ^b   Krausz, Thomas ^b   Neal, David ^c   Thomas, David ^c   Hanby, Andrew ^a   Balkwill, Frances ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE; MESSENGER RNA; METALLOPROTEINASE;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; STROMA; TRANSITIONAL CELL CARCINOMA;

BLADDER; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; COLLAGENASES; GELATINASE A; GELATINASE B; GELATINASES; HUMAN; IN SITU HYBRIDIZATION; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; RNA, MESSENGER;

EID: 0027384917     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
2. Matrisian, L.M., and Bowden, G.T. Stromelysin/transin and tumor progression. Semin. Cancer Biol., 1: 107-116, 1990.
3. Pyke, C., Ralfliaer, E., Huhtala, P., Hurslainen, T., Dano, K., and Tryggvason, K. Localization of messenger RNA for Mr 72, 000 and 92, 000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52: 1336-1341, 1992.
4. Pyke, C., Ralfkiaer, E., Tryggvason, K., and Dano, K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142: 359-364, 1993.
5. Davies, B., Miles, D.W., Happerfield, L.C., Naylor, M.S., Bobrow; L.G., Rubens, R.D., and Balkwill, F.R., Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67: 1126-1131, 1993.
6. Stearns, M.E., and Wang, M. Type IV collagenase (Mr 72, 000) expression in human prostrate: benign and malignant tissue. Cancer Res., 53: 878-883, 1993.
7. Brown, P.D., Levy, A.T., Margulies, I.M.K., Liotta, L.A., and Stetler-Stevenson, W.G., Indepenedent expression and cellular processing of Mr 72, 000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50: 6184-6191, 1990.
8. Naylor, M.S., Stamp, G.W.H., and Balkwill, F.R. Investigation of cytokine gene expression in human colorectal cancer. Cancer Res., 50: 4436-4440, 1990.
9. Cuzick, J. A Wilcoxon-type test for trend. Statistics Med., 4: 87-90, 1985.
10. Brown, P.D., Bloxidge, R.E., Anderson, E., and Howell, A. Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis 11: 183-189, 1993.
11. Brown, P.D., Bloxidge, R.E., Stuart, N.S.A., Gaiter, K.C., and Carmichael, J. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J. Natl. Cancer Inst., 85: 574-578, 1993.
12. Waxman, J., and Wasan, H., The architecture of cancer: tissue metalloproteinases amd their inhibitors. Br. Med. J., 305: 1306-1307, 1993.
13. Garbisa, S., Pozzatti, R., Muschel, R.J., Saffiotti, U., Ballin, M., Goldfarb, R.H., Khoury, G., and Liotta, L.A. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res., 47: 1523-1528, 1987.
14. Alvarez, O.A., Carmichael D.F., and De Clerck, Y.A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst., 82: 589-595, 1990.
15. Monteagudo, C., Merino, M.J., San-Juan, J., Liotta, L.A., and Stetler-Stevenson, W.G. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
16. Hibbs, M.S., Hoidaland, J.R., and Kang, A.H. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest., 80: 1644-1650, 1987.
17. Welgus, H.G., Campbell, E.J., Cury, J.D., Eisen, A.Z., Senoir, R.M., Wilhelm, S.M., and Goldberg, G.I. Neutral metalloproteinases produced by human mononuclear phagocytes. J. Clin. Invest., 86: 1496-1502, 1990.
18. Overall, C.M., and Sodek, J., Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J. Biol. Chem., 265: 21141-21151, 1990.
19. Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J.P., Reynolds, J.J., and Murphy, G. Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta, 1079: 242-246, 1991.
20. Able, P.D. Follow up of patients with “superficial” transitional cell carcinoma of the bladder. The case for a change in policy. Br. J. Urol., 72: 135-142, 1993.